DAX23.970 -1,0%ESt505.338 -0,3%Top 10 Crypto16,23 +2,0%Dow44.762 -0,3%Nas21.138 +0,1%Bitcoin101.610 ±0,0%Euro1,1593 -1,3%Öl70,22 +2,7%Gold3.316 -0,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Volkswagen (VW) vz. 766403 RENK RENK73 Mercedes-Benz Group (ex Daimler) 710000 Lufthansa 823212 Bayer BAY001 Deutsche Bank 514000 BASF BASF11 Tesla A1CX3T DroneShield A2DMAA Porsche PAG911 Novo Nordisk A3EU6F HENSOLDT HAG000 Deutsche Telekom 555750
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-EU-Zolldeal im Blick: DAX schließt unter 24.000 Punkten -- US-Börsen uneins -- NVIDIA-Aktie: Huawei stellt Konkurrenzsystem vor -- TUI, Amazon, Clara Tech, D-Wave, PUMA, Intel im Fokus
Top News
Clara Technologies-Aktie: Spannende Bilanz im August voraus - Anleger in Wartestellung Clara Technologies-Aktie: Spannende Bilanz im August voraus - Anleger in Wartestellung
Warum der Euro nach dem EU-/USA-Zolldeal nachgibt Warum der Euro nach dem EU-/USA-Zolldeal nachgibt
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Ãœbersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Eli Lilly Aktie

Handeln
Eli Lilly Aktien-Sparplan
703,50 EUR +13,50 EUR +1,96 %
FSE
805,06 USD -7,89 USD -0,97 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.656,84 Mrd. EUR

KGV65,91Div. Rendite0,67%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN858560

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS5324571083

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolLLY

Eli Lilly Aktien News

DatumMeistgelesen
EN, Eli LillyLilly announces retirement of Marschall S. Runge from its Board of Directors
PR NewswireLilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
EN, Eli LillyLilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
ZacksWhat Makes Eli Lilly (LLY) a Strong Momentum Stock: Buy Now?
BenzingaEli Lilly Unusual Options Activity For August 15
MotleyFoolPrediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
BenzingaDon't Promote Copycat Weight-Loss Drugs Amid Improved Supply, Eli Lilly Asks Doctors, FDA Evaluates
BenzingaEli Lilly Smashed Estimates Thanks To Unbelievable Demand For Its Diabetes And Weight Loss Blockbusters
ZacksIs Eli Lilly (LLY) a Buy Post Stellar Q2 Earnings & Raised View?
ZacksThe Zacks Analyst Blog Highlights Eli Lilly, Pfizer, AbbVie and Biogen
MotleyFoolUp 10% in 1 Day, Is It Too Late to Buy Eli Lilly Stock?
BenzingaHere's How Much You Would Have Made Owning Eli Lilly Stock In The Last 10 Years
ZacksInvestors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
EN, Eli LillyLilly opens state-of-the-art research and development center in the Boston Seaport
PR NewswireLilly opens state-of-the-art research and development center in the Boston Seaport
MotleyFoolThis 1 Piece of Good News for Eli Lilly Is Bad News for Hims & Hers Health Stock
MotleyFoolWhy Eli Lilly Stock's Big Jump Last Week Could Be Just the Beginning of Another Huge Run
BenzingaEli Lilly To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Monday
BenzingaBeyond The Numbers: 25 Analysts Discuss Eli Lilly Stock
BenzingaAnalyzing Eli Lilly In Comparison To Competitors In Pharmaceuticals Industry
BenzingaEli Lilly Unusual Options Activity
MarketWatchThese stocks join Meta and Eli Lilly as the biggest winners this earnings season
MotleyFoolWhy Eli Lilly Stock Just Jumped 8%
BenzingaParker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday
PR NewswireLilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue Guidance by $3 Billion
EN, Eli LillyLilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue Guidance by $3 Billion
BenzingaWhat's Going On With Eli Lilly And Company Shares Wednesday?
BenzingaWhat's Going On With Eli Lilly and Company Shares Friday
MotleyFoolAre Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
PR NewswireLilly's tirzepatide successful in phase 3 study showing benefit in adults with heart failure with preserved ejection fraction and obesity
EN, Eli LillyLilly's tirzepatide successful in phase 3 study showing benefit in adults with heart failure with preserved ejection fraction and obesity
ZacksHere is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
BenzingaThis Is What Whales Are Betting On Eli Lilly and Co
BenzingaUnpacking the Latest Options Trading Trends in Eli Lilly and Co
BenzingaAnalyzing Eli Lilly and Co In Comparison To Competitors In Pharmaceuticals Industry
PR NewswireLilly Confirms Date and Conference Call for Second-Quarter 2024 Financial Results Announcement
PR NewswireLilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
PR NewswireLilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease
PR NewswireLilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria
PR NewswireLilly Declares Third-Quarter 2024 Dividend

Eli Lilly News

Eli Lilly News: auf dieser Seite finden Sie alle Eli Lilly News und Nachrichten zur Eli Lilly Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Eli Lilly News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Eli Lilly News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.